Kazia Therapeutics (KZIA) Other Non-Current Liabilities (2009 - 2025)
Kazia Therapeutics (KZIA) posted Other Non-Current Liabilities of $5047.1 for Q4 2025, up 2.52% on a QoQ basis from $4923.0 in Q2 2025, and down 99.78% year-over-year from $2.3 million in Q4 2024.
Kazia Therapeutics (KZIA) has 14 years of Other Non-Current Liabilities data on file, last reported at $5047.1 in Q4 2025.
- In Q4 2025, Other Non-Current Liabilities fell 99.78% year-over-year to $5047.1; the TTM figure through Dec 2025 stood at $5047.1 (down 99.78% YoY), while the FY2025 annual figure was $4923.0, down 99.8% from the prior year.
- Other Non-Current Liabilities rose to $5047.1 in Q4 2025, from $4923.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $6.9 million in Q2 2021 and bottomed at $4923.0 in Q2 2025.
- A 5-year average of $3.4 million and a median of $3.6 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities surged 2190.03% — and 2025, when it plunged 99.8%.
- Year by year, Other Non-Current Liabilities stood at $6.9 million in 2021, then slipped by 22.41% to $5.3 million in 2022, then sank by 32.14% to $3.6 million in 2023, then slumped by 36.49% to $2.3 million in 2024, then sank by 99.78% to $5047.1 in 2025.
- The last three Other Non-Current Liabilities figures came in at $5047.1 (Q4 2025), $4923.0 (Q2 2025), and $2.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,047.10 |
| Jun 30, 2025 | 4,923.01 |
| Dec 31, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Dec 31, 2023 | 3.62 Mn |
| Jun 30, 2023 | 4.09 Mn |
| Dec 31, 2022 | 5.33 Mn |
| Jun 30, 2022 | 5.88 Mn |
| Jun 30, 2021 | 6.87 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Jun 30, 2020 | 300,182.65 |
| Dec 31, 2019 | 1.09 Mn |
| Jun 30, 2019 | 960,347.49 |
| Dec 31, 2018 | 676,587.43 |
| Jun 30, 2018 | 785,047.28 |
| Jun 30, 2017 | 48,077.46 |
| Dec 31, 2016 | 2.89 Mn |
| Jun 30, 2016 | 2.48 Mn |
| Jun 30, 2012 | 192,001.40 |
| Dec 31, 2011 | 717,845.67 |
| Jun 30, 2011 | 817,496.48 |
| Dec 31, 2010 | 542,196.53 |
| Jun 30, 2010 | 527,769.67 |
| Dec 31, 2009 | 643,538.08 |
| Jun 30, 2009 | 587,425.10 |